B

BiohacksAI

Evidence-Based Biohacking

Patent Pending

FOXM1

MOLECULAR TARGET

forkhead box M1

UniProt: Q08050NCBI Gene: 23051 compounds

FOXM1 (forkhead box M1) is targeted by 1 compounds in the BiohacksAI evidence corpus, derived from PubMed bioassay data. Each compound is ranked by confidence score (log-normalized assay count × evidence quality).

Compounds Targeting FOXM1

Ranked by bioassay confidence score (PubChem active assay count × evidence quality).

#CompoundConfidenceActive Assays
1Troglitazone1.102

About FOXM1 as a Drug Target

FOXM1 (forkhead box M1) is a well-characterized molecular target in biomedical research. BiohacksAI tracks 1 compounds with documented FOXM1 interaction from PubChem bioassay data, cross-referenced with PubMed clinical evidence. The confidence score reflects the log-normalized count of active PubChem assays, weighted by evidence quality from the BiohacksAI corpus.

FOXM1 inhibitors, activators, and modulators are of interest in research areas including longevity, metabolic health, and neurological function. Each compound profile includes evidence score, RCT count, human study ratio, research velocity, and domain relevance.